Susquehanna International Group
IBB icon

Susquehanna International Group’s iShares Biotechnology ETF IBB Stock Holding History

Susquehanna International Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66M Sell
391,000
-178,700
-31% -$30.6M 0.01% 1082
2025
Q4 		$96.1M Buy
569,700
+100,500
+21% +$16.3M 0.01% 912
2025
Q3 		$67.7M Buy
469,200
+159,400
+51% +$21.8M 0.01% 1137
2025
Q2 		$39.2M Sell
309,800
-512,200
-62% -$62.9M 0.01% 1352
2025
Q1 		$105M Buy
822,000
+34,300
+4% +$4.65M 0.02% 629
2024
Q4 		$104M Sell
787,700
-812,300
-51% -$114M 0.02% 688
2024
Q3 		$233M Buy
1,600,000
+817,300
+104% +$118M 0.04% 353
2024
Q2 		$107M Buy
782,700
+213,200
+37% +$28.5M 0.02% 572
2024
Q1 		$78.1M Sell
569,500
-639,600
-53% -$87.3M 0.01% 787
2023
Q4 		$164M Buy
1,209,100
+818,700
+210% +$99.9M 0.03% 473
2023
Q3 		$47.7M Sell
390,400
-45,100
-10% -$5.74M 0.01% 1040
2023
Q2 		$55.3M Buy
435,500
+95,900
+28% +$12.5M 0.01% 924
2023
Q1 		$43.9M Sell
339,600
-18,700
-5% -$2.45M 0.01% 1035
2022
Q4 		$47M Sell
358,300
-94,400
-21% -$12.2M 0.01% 915
2022
Q3 		$53.2M Buy
452,700
+190,400
+73% +$23.6M 0.01% 768
2022
Q2 		$30.9M Buy
262,300
+81,200
+45% +$9.64M 0.01% 1133
2022
Q1 		$23.6M Sell
181,100
-269,000
-60% -$35M ﹤0.01% 1569
2021
Q4 		$68.7M Buy
450,100
+21,500
+5% +$3.33M 0.01% 908
2021
Q3 		$69.3M Sell
428,600
-58,100
-12% -$9.78M 0.01% 965
2021
Q2 		$79.6M Sell
486,700
-377,800
-44% -$58.2M 0.01% 898
2021
Q1 		$130M Sell
864,500
-728,400
-46% -$116M 0.02% 607
2020
Q4 		$241M Buy
1,592,900
+278,600
+21% +$39.8M 0.04% 369
2020
Q3 		$178M Buy
1,314,300
+134,000
+11% +$18.2M 0.03% 374
2020
Q2 		$161M Sell
1,180,300
-47,300
-4% -$6.03M 0.04% 361
2020
Q1 		$132M Sell
1,227,600
-280,400
-19% -$32.3M 0.04% 315
2019
Q4 		$182M Buy
1,508,000
+861,300
+133% +$96.1M 0.05% 296
2019
Q3 		$64.3M Sell
646,700
-491,900
-43% -$51.5M 0.02% 618
2019
Q2 		$124M Buy
1,138,600
+667,400
+142% +$71M 0.05% 347
2019
Q1 		$52.7M Sell
471,200
-866,300
-65% -$95M 0.02% 603
2018
Q4 		$129M Buy
1,337,500
+575,100
+75% +$61M 0.05% 311
2018
Q3 		$93M Sell
762,400
-161,000
-17% -$19M 0.03% 467
2018
Q2 		$101M Sell
923,400
-759,500
-45% -$81.2M 0.03% 411
2018
Q1 		$180M Sell
1,682,900
-978,700
-37% -$108M 0.06% 238
2017
Q4 		$284M Buy
2,661,600
+217,500
+9% +$23.2M 0.1% 169
2017
Q3 		$272M Buy
2,444,100
+246,600
+11% +$26.4M 0.11% 161
2017
Q2 		$227M Buy
2,197,500
+1,402,200
+176% +$138M 0.1% 171
2017
Q1 		$77.7M Sell
795,300
-1,640,700
-67% -$157M 0.04% 409
2016
Q4 		$215M Sell
2,436,000
-137,700
-5% -$12.5M 0.11% 158
2016
Q3 		$248M Sell
2,573,700
-1,675,800
-39% -$159M 0.12% 133
2016
Q2 		$365M Buy
4,249,500
+702,900
+20% +$63.1M 0.2% 78
2016
Q1 		$308M Sell
3,546,600
-879,300
-20% -$78.6M 0.16% 94
2015
Q4 		$499M Sell
4,425,900
-672,900
-13% -$73M 0.23% 62
2015
Q3 		$516M Buy
5,098,800
+1,452,300
+40% +$174M 0.22% 66
2015
Q2 		$448M Buy
3,646,500
+846,600
+30% +$101M 0.19% 68
2015
Q1 		$321M Buy
2,799,900
+1,384,800
+98% +$153M 0.15% 113
2014
Q4 		$143M Buy
1,415,100
+44,700
+3% +$4.34M 0.06% 300
2014
Q3 		$125M Sell
1,370,400
-579,900
-30% -$50.9M 0.05% 349
2014
Q2 		$167M Sell
1,950,300
-1,499,100
-43% -$118M 0.07% 229
2014
Q1 		$272M Buy
3,449,400
+2,146,500
+165% +$179M 0.13% 121
2013
Q4 		$98.6M Buy
1,302,900
+625,500
+92% +$44.4M 0.05% 356
2013
Q3 		$47.3M Sell
677,400
-266,100
-28% -$17.4M 0.03% 618
2013
Q2 		$54.7M Buy
+943,500
New +$54.5M 0.03% 516

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's IBB Position: Q1 2026 in Review

Susquehanna International Group reduced its iShares Biotechnology ETF (IBB) stake by 80% in Q1 2026, selling an estimated $41.5M and leaving 61,634 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

Susquehanna International Group first reported a position in IBB in Q2 2013 and has held it in 47 quarters since. The position peaked at $80.7M in Q2 2014. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Susquehanna International Group held 61,634 shares of iShares Biotechnology ETF worth $10.4M as of Q1 2026.
  • Susquehanna International Group sold 242,512 iShares Biotechnology ETF shares in Q1 2026, an estimated $41.5M.
  • iShares Biotechnology ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3054 holding.
  • Susquehanna International Group first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's iShares Biotechnology ETF position peaked at $80.7M in Q2 2014.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.